Didier Decaudin

10.2k citations

148 papers · 7.0k indexed · 1 hit paper · h-index 39

Impact in

Oncology top 1%
- Viral-associated cancers and disorders
- Cancer Cells and Metastasis
Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment

Papers in

Pathology and Forensic Medicine 41
- Lymphoma Diagnosis and Treatment 36
Ophthalmology 19
- Ocular Oncology and Treatments 19

Co-authors: Guido Kroemer Tamara Hirsch Santos A. Susín Philippe Marchetti Naoufal Zamzami Antonio Macho Maria Castedo Bernard Mignotte
Journals: Anti-Cancer Drugs (11 papers)Cancer Research (8 papers)Blood (8 papers)Oncotarget (5 papers)PLoS ONE (5 papers)
Partner nations: France United States Netherlands

In The Last Decade

Didier Decaudin

142 papers receiving 6.8k citations

Hit Papers

align trajectories log scale

Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. 1995 · 1.4k citations

Peers

Countries citing papers authored by Didier Decaudin

Since Specialization

Citations

This map shows the geographic impact of Didier Decaudin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Decaudin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Decaudin more than expected).

Fields of papers citing papers by Didier Decaudin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Decaudin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Decaudin. The network helps show where Didier Decaudin may publish in the future.

Co-authors

The 25 scholars most cited alongside Didier Decaudin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Didier Decaudin Line = papers co-authored together Didier Decaudin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin Nature ·J Ruiz Vidal, Zackie Aktary, 田村五郎, Valérie Petit, Flavie Luciani, Gnanasekeran Chandiran, Patrick Gizzi, Коган Евгений Геннадьевич, Didier Decaudin, Fariba Némati, Igor Martianov, Irwin Davidson, Catherine Tomasetto, Richard M. White, Florence Mahuteau‐Betzer, B. Vergier, Lionel Larue, Véronique Delmas	2025	4
2	Biodegradable Polymeric Delivery Systems of Ruthenium(II) Polypyridyl Complexes for the Treatment of High-Grade Epithelial Ovarian Cancer Chemistry of Materials ·Huaying Cao, Kateřina Svobodová, Fariba Némati, Olivia Marx, 誠一井上, Fan Sun, Carine Robert, Olivier Blacque, Didier Decaudin, C.M. Thomas, Gilles Gasser	2025	0
3	Non-canonical miRNA-RNA base-pairing impedes tumor suppressor activity of miR-16 Life Science Alliance ·Anaïs M. Quéméner, Laura Bachelot, Marc Aubry, Stéphane Avner, Delphine Leclerc, Gilles Salbert, Florian Cabillic, Didier Decaudin, Bernard Mari, F. Mouriaux, Marie‐Dominique Galibert, David Gilot	2022	4
4	Polymeric encapsulation of a ruthenium( ii ) polypyridyl complex: from synthesis to in vivo studies against high-grade epithelial ovarian cancer Chemical Science ·João P. M. António, Albert Gandioso, Fariba Némati, Fouzia Houma Bachari, Robin Vinck, Fan Sun, Carine Robert, Pierre Bürckel, Didier Decaudin, C.M. Thomas, Gilles Gasser	2022	20
5	Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1–derived peptides overcomes drug resistance Blood Advances ·Raul T. Santos, J. W. T. Duvel, 榮治千葉, Fariba Némati, Malina Xiao, Shao Zaicui, Karim Maloum, Damien Roos‐Weil, Élise Chapiro, Magali Le Garff‐Tavernier, Frédéric Davi, Didier Decaudin, Marika Sarfati, Florence Nguyen‐Khac, Hélène Merle‐Béral, Philippe Karoyan, Santos A. Susín	2019	9
6	Sensitization of EGFR Wild-Type Non–Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib Molecular Cancer Therapeutics ·Judith Raimbourg, Marie‐Pierre Joalland, Mathilde Cabart, Ludmilla de Plater, Fanny Bouquet, Ariel Savina, Didier Decaudin, Jaafar Bennouna, François M. Vallette, Lisenn Lalier	2017	17
7	Identification of ras/raf binding site and design of interfering peptide with potential clinical application Integrative Molecular Medicine ·Lin Tian, Deng-Chao Wang, Fariba Némati, 七川尭, Christian Caizaluisa, Didier Decaudin, 喜典森本, 谢丽娴, Abdessamad Snoussi Amouri, PATRICIA CASEY, Oliver-Mark Cordes, J Haden, Séverine Loisel, Angelita Rebollo	2016	6
8	Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy EMBO Molecular Medicine ·Nesrine Benkafadar, J R Andrews, Jérôme Bourien, Régis Nouvian, Florence François, Didier Decaudin, Domenico Maiorano, Jean‐Luc Puel, Jing Wang	2016	77
9	Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage Polarization PLoS ONE ·七川尭, Gérald Massonnet, Shaheen Ahmed, David Gentien, Zofia Maciorowski, Pierre de la Grange, Brigitte Sigal‐Zafrani, Marion Richardson, Sandrine Humbert, Aurélie Thuleau, Franck Assayag, Ludmilla de Plater, Nicolás André, Suzy Scholl, Elisabetta Marangoni, Stefan Weigand, Sergio Roman‐Roman, Ariel Savina, Didier Decaudin	2016	9
10	Establishment of an Orthotopic Xenograft Mice Model of Retinoblastoma Suitable for Preclinical Testing Ocular Oncology and Pathology ·Nathalie Cassoux, E F Hammel, Franck Assayag, Isabelle Aerts, Didier Decaudin	2015	7
11	Acquired Resistance to Endocrine Treatments Is Associated with Tumor-Specific Molecular Changes in Patient-Derived Luminal Breast Cancer Xenografts Clinical Cancer Research ·Paul Cottu, Ivan Bièche, Franck Assayag, Rania El Botty, Sophie Château‐Joubert, Aurélie Thuleau, Iader Giraldo, Benoît Albaud, Audrey Rapinat, David Gentien, Pierre de la Grange, Vonick Sibut, Sophie Vacher, Abrahamsson Beatrice, Jean‐Luc Servely, Jean‐Jacques Fontaine, Didier Decaudin, Jean‐Yves Pierga, Sergio Roman‐Roman, Elisabetta Marangoni	2014	42
12	Vasculature analysis of patient derived tumor xenografts using species-specific PCR assays: evidence of tumor endothelial cells and atypical VEGFA-VEGFR1/2 signalings BMC Cancer ·Ivan Bièche, Sophie Vacher, 七川尭, Sophie Richon, Abrahamsson Beatrice, Ludmilla de Plater, Ahmed Dahmani, Fariba Némati, Eric Angevin, Elisabetta Marangoni, Sergio Roman‐Roman, Didier Decaudin, Virginie Dangles‐Marie	2014	20
13	Pyrophosphorolysis-Activated Polymerization Detects Circulating Tumor DNA in Metastatic Uveal Melanoma Clinical Cancer Research ·Jordan Madic, Sophie Piperno‐Neumann, Vincent Servois, Aurore Rampanou, Maud Milder, Bénédicte Trouiller, David Gentien, Mira Farouk Youssef, Franck Assayag, Aurélie Thuleau, Fariba Némati, Didier Decaudin, François‐Clément Bidard, Laurence Desjardins, Pascale Mariani, Olivier Lantz, Marc‐Henri Stern	2012	65
14	Inhibiting Aurora Kinases Reduces Tumor Growth and Suppresses Tumor Recurrence after Chemotherapy in Patient-Derived Triple-Negative Breast Cancer Xenografts Molecular Cancer Therapeutics ·Angela Romanelli, Nils Demary, Franck Assayag, Sophie Château‐Joubert, Marie‐France Poupon, Jean‐Luc Servely, Jean‐Jacques Fontaine, Xiaohong Liu, E. T. C. Spooner, L. Frommer, Patricia de Crémoux, Ivan Bièche, Didier Decaudin, Elisabetta Marangoni	2012	40
15	Molecular profiling of patient-derived breast cancer xenografts Breast Cancer Research ·Fabien Reyal, Charlotte Guyader, Charles Decraene, Carlo Lucchesi, Nathalie Auger, Franck Assayag, Ludmilla de Plater, David Gentien, Marie‐France Poupon, Paul Cottu, Patricia de Crémoux, Pierre Gestraud, Anne Vincent‐Salomon, Jean‐Jacques Fontaine, Sergio Roman‐Roman, Olivier Delattre, Didier Decaudin, Elisabetta Marangoni	2012	140
16	Tumor Delivery of Ultrasound Contrast Agents Using Shiga Toxin B Subunit Molecular Imaging ·Olivier Couture, Estelle Dransart, Harison Citrawan, Fariba Némati, Didier Decaudin, Ludger Johannes, Mickaël Tanter	2011	25
17	90yttrium Ibritumomab Tiuxetan (zevalin) Combined With Beam (z-beam) Conditioning Regimen Plus Autologous Stem Cell Transplantation in Relapsed Or Refractory Follicular Lymphoma. a Gela Phase Ii Prospective Study Digital Access to Libraries ·Christian Gisselbrecht, Didier Decaudin, Nicolas Mounier, Hervé Tilly, Vincent Ribrag, Catherine Sebban, Nöel Milpied, Franck Morschhauser, Bertrand Coiffier, Steven Le Gouill, P Lederlin, Richard Delarue, G. Laurent, André Bosly	2009	1
18	Graft-Versus-Lymphoma Effect for Aggressive T-Cell Lymphomas in Adults: A Study by the Société Française de Greffe de Moëlle et de Thérapie Cellulaire Journal of Clinical Oncology ·Steven Le Gouill, Nöel Milpied, Agnès Buzyn, Régis Peffault de Latour, Jean‐Paul Vernant, Mohamad Mohty, Marie‐Pierre Moles, Krimo Bouabdallah, Claude‐Eric Bulabois, Jehan Dupuis, Bernard Rio, N Gratecos, Ibrahim Yakoub‐Agha, Michel Attal, Olivier Tournilhac, Didier Decaudin, 韮澤融司, Didier Blaise, Christelle Volteau, Mauricette Michallet	2008	208
19	Shiga Toxin‐Mediated Retrograde Delivery of a Topoisomerase I Inhibitor Prodrug Angewandte Chemie International Edition ·Brittany N. Turba, Frédéric Schmidt, Mohamed Amessou, R. Piria, Didier Decaudin, Jean‐Claude Florent, Ludger Johannes	2007	66
20	Clinical Efficacy of Irradiation in CLL Patients: Predictive Value of in Vitro Radio-induced Apoptosis Leukemia & lymphoma ·Didier Decaudin, Jozo Delić, J Dumont, G. Tertian, Emmanuel Blot, Bernard Dubray, C. Grandpeix, Régis Peffault de Latour, Jean‐Marc Cosset	2002	3

About Didier Decaudin

Didier Decaudin is a scholar working on Pathology and Forensic Medicine, Ophthalmology, Oncology, Genetics and Immunology, having authored 148 papers that have together received 7.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (36 papers), Ocular Oncology and Treatments (19 papers), CNS Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (11 papers), Cancer Cells and Metastasis (10 papers), Cell death mechanisms and regulation (10 papers), Viral-associated cancers and disorders (10 papers) and Cancer-related Molecular Pathways (9 papers). The work is most often cited by research in Oncology (1.8k citations), Pathology and Forensic Medicine (1.2k citations), Immunology (1.2k citations), Molecular Biology (3.6k citations) and Cancer Research (765 citations). Didier Decaudin has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include Guido Kroemer, Tamara Hirsch, Santos A. Susín, Philippe Marchetti, Naoufal Zamzami, Antonio Macho, Maria Castedo, Bernard Mignotte, Patrice X. Petit and Fariba Némati. Their work appears in journals such as Anti-Cancer Drugs, Cancer Research, Blood, Oncotarget and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact